pz01 car-t cells
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2017 (NCT03281551)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Protein tyrosine phosphatase receptor type C-associated proteinImmunity, passive
PTPRCAP immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03281551 | Phase 1 | Oct 1, 2017 | Chinese Academy of Medical Sciences, Government of China, Pinze Lifetechnology Co. Ltd. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Government of China | Government | 1 | 0 | 1 | 2017 |
| Pinze Lifetechnology Co. Ltd. | Government | 1 | 1 | 1 | 2017 |
3 organizations
Page 1 / 1